AcquisitionsMay 13, 2026, 04:32 PM
Prestige Consumer Healthcare Acquires LaCorium; FY26 Adj. EPS $4.38
AI Summary
Prestige Consumer Healthcare Inc. announced an agreement to acquire LaCorium Health for approximately $150 million, expanding its therapeutic skin care portfolio in Australia and globally. The company reported a decline in both fourth quarter and full fiscal year 2026 revenues and adjusted diluted EPS, with full-year revenues at $1,088.7 million and adjusted diluted EPS at $4.38. Despite the financial declines, the company generated strong free cash flow of $246.4 million and provided an optimistic fiscal year 2027 outlook, projecting Adjusted Diluted EPS of $4.42 to $4.51 and over $250 million in free cash flow.
Key Highlights
- Agreed to acquire LaCorium Health for approximately $150 million in cash, adding $40 million in trailing 12-month revenue.
- Reported fiscal year 2026 revenues of $1,088.7 million, a 4.3% decrease from the prior year.
- Achieved fiscal year 2026 Adjusted Diluted EPS of $4.38, down from $4.52 in the prior year.
- Reported fourth quarter 2026 revenues of $281.6 million, a 5.0% decrease from the prior year comparable period.
- Reported fourth quarter 2026 Adjusted Diluted EPS of $1.23, down from $1.32 in the prior year comparable period.
- Generated $246.4 million in free cash flow in fiscal year 2026, an increase from $243.3 million in the prior year.
- Repurchased 2.3 million shares for approximately $156 million in fiscal year 2026.
- Provided fiscal year 2027 outlook for Adjusted Diluted EPS of $4.42 to $4.51 and free cash flow of $250 million or more.